QuantiFERON Monitor (QFM) is an in vitro diagnostic test that detects interferon-γ (IFNγ) following incubation of heparinized whole blood with innate and adaptive immune response stimulants.
QuantiFERON Monitor (QFM) is an in vitro diagnostic test detecting interferon-γ (IFNγ) following incubation of heparinized whole blood with innate and adaptive immune response stimulants.
The assay is used to detect cell mediated immune response in immunosuppressed solid organ transplant patients.
QuantiFERON Monitor is intended for use in conjunction with risk assessment and other medical and diagnostic evaluations.
- Assesses cell-mediated immune (CMI) response
- Provides nonpathogen-specific immune monitoring
- Complements pathogen-specific monitoring
- Aids in clinical management of solid organ transplant patients
Maintain the optimal therapeutic window for your patients
Find the right balance with QuantiFERON Monitor
Providing insight into your patients’ immune status
Patient immunosuppression is a necessity for successful solid organ transplantation.
Other interesting content
Looking for something else? You might be interested in this as well.
QuantiFERON® reasearch papers – Follow the latest studies
Latest research applications of T cell assays in SARS-CoV-2 infections, immunity investigations and patient monitoring
QFT CMV – Monitor transplant patient’s level of anti-CMV immunity
QuantiFERON® – CMV is a blood test that measures the immune response of CD8+ cells to CMV. The test is used to monitor people’s risks of developing CMV disease and can be used in connection with organ transplants to predict whether patients have an increased risk of developing CMV disease.
Please, reach out if you have questions, comments or requests.